HighMark Wealth Management LLC - QUALIGEN THERAPEUTICS INC ownership

QUALIGEN THERAPEUTICS INC's ticker is and the CUSIP is 74754R202. A total of 20 filers reported holding QUALIGEN THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HighMark Wealth Management LLC ownership history of QUALIGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$1,380
-56.9%
8,0090.0%0.00%
-50.0%
Q1 2024$3,204
-27.3%
8,0090.0%0.00%
-33.3%
Q4 2023$4,405
-45.5%
8,0090.0%0.00%
-57.1%
Q3 2023$8,089
+10.9%
8,0090.0%0.01%
+40.0%
Q2 2023$7,296
-1.5%
8,0090.0%0.01%
-16.7%
Q1 2023$7,409
-28.2%
8,0090.0%0.01%
-25.0%
Q4 2022$10,3248,0090.01%
Other shareholders
QUALIGEN THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
HighMark Wealth Management LLC 8,009$7,4090.01%
US BANCORP \DE\ 824$7620.00%
WELLS FARGO & COMPANY/MN 29$270.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 11,277$10,4310.00%
Retirement Group, LLC 350$00.00%
Archer Investment Corp 16$150.00%
GEODE CAPITAL MANAGEMENT, LLC 22,329$20,6580.00%
BlackRock Inc. 25,840$23,9050.00%
ICA Group Wealth Management, LLC 245$2270.00%
View complete list of QUALIGEN THERAPEUTICS INC shareholders